Nais Prade

Toulouse, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Targeted Next-Generation Sequencing of JAK2, CALR, and MPL in 10 326 Patients With Suspected Myeloproliferative Neoplasm.

Targeted Next-Generation Sequencing of JAK2, CALR, and MPL in 10 326 Patients With Suspected Myeloproliferative Neoplasm.

Journal: American journal of hematology
Published: April 29, 2026

Structural and functional consequences of IL33 and IL1RL1 coding variants on IL-33/ST2 signaling.

Structural and functional consequences of IL33 and IL1RL1 coding variants on IL-33/ST2 signaling.

Journal: Genes and immunity
Published: January 15, 2026

Signals from the bone marrow B cell niches shape pre-leukemic fate in a murine model of B cell acute lymphoblastic leukemia.

Signals from the bone marrow B cell niches shape pre-leukemic fate in a murine model of B cell acute lymphoblastic leukemia.

Journal: Oncogene
Published: August 05, 2025

Selumetinib as an Effective Therapy of Histiocytic Sarcoma Evolving From a B-Cell Acute Lymphoblastic Leukaemia.

Selumetinib as an Effective Therapy of Histiocytic Sarcoma Evolving From a B-Cell Acute Lymphoblastic Leukaemia.

Journal: EJHaem
Published: April 29, 2025

GATA2 mutated allele specific expression is associated with a hyporesponsive state of HSC in GATA2 deficiency syndrome.

GATA2 mutated allele specific expression is associated with a hyporesponsive state of HSC in GATA2 deficiency syndrome.

Journal: Blood cancer journal
Published: December 02, 2024

Modeling the PAX5P80R Mutation Reveals HIF2α Activation as a Common Feature and Therapeutic Target in B-cell Acute Lymphoblastic Leukemia.

Modeling the PAX5P80R Mutation Reveals HIF2α Activation as a Common Feature and Therapeutic Target in B-cell Acute Lymphoblastic Leukemia.

Journal: Cancer research
Published: May 21, 2024

Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL.

Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL.

Journal: The Journal of experimental medicine
Published: February 14, 2023

Somatic genetic alterations predict hematological progression in GATA2 deficiency.

Somatic genetic alterations predict hematological progression in GATA2 deficiency.

Journal: Haematologica
Published: October 13, 2022

Genomic landscape of hyperleukocytic acute myeloid leukemia.

Genomic landscape of hyperleukocytic acute myeloid leukemia.

Journal: Blood cancer journal
Published: October 26, 2021

GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1.

GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1.

Journal: Blood advances
Published: May 19, 2021

The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.

The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.

Journal: Blood advances
Published: May 18, 2021

del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma.

del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma.

Journal: Blood
Published: July 22, 2020
Showing 1-12 of 28

Last Updated: 09/26/2026